A First in Human Study of ORT247 in Healthy Volunteers
Status:
COMPLETED
Trial end date:
2023-10-24
Target enrollment:
Participant gender:
Summary
This is a single center, double-blinded, randomized, placebo controlled single ascending dose clinical study, with the primary purpose of evaluating the safety, tolerability, pharmacokinetics (PK), and immunohistochemistry of escalating intravenous doses of ORT247 in healthy volunteers.